Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Journal of Clinical and Experimental Hematopathology : JCEH
|
December 3, 2010
Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases
Minoru Kojima, Eriko Sato, Kazuo Oshimi, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
August 10, 2018
The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation
Noriaki Kawano, Shuro Yoshida, Sayaka Kawano, et al.
Blood Cell Therapy
|
June 10, 2024
A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells
Ken Takigawa, Noriaki Kawano, Yasuo Mori, et al.
Internal Medicine (Tokyo, Japan)
|
April 19, 2019
Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)
Noriaki Kawano, Noriaki Yoshida, Sayaka Kawano, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
June 28, 2023
The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL)
Noriaki Kawano, Hidemi Shimonodan, Yuri Nagahiro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 22, 2022
[Analysis of Prognostic Factors Considering Absolute Lymphocyte Count of Metastatic Breast Cancer Patients with Eribulin Mesylate Therapy-A Retrospective Study in a Single Institution]
Yuichi Ueda, Yuko Makino, Hideki Hidaka, et al.
International Journal of Hematology
|
July 11, 2018
Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia
Ayako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
International Journal of Hematology
|
March 1, 2018
Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan
Ayako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
Blood
|
November 15, 2014
Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator
Takuro Kameda, Kotaro Shide, Takumi Yamaji, et al.
Blood Cell Therapy
|
September 10, 2025
The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy
Takashi Shimakawa, Noriaki Kawano, Yuichiro Semba, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Journal of Clinical and Experimental Hematopathology : JCEH
|
December 3, 2010
Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases
Minoru Kojima, Eriko Sato, Kazuo Oshimi, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
August 10, 2018
The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation
Noriaki Kawano, Shuro Yoshida, Sayaka Kawano, et al.
Blood Cell Therapy
|
June 10, 2024
A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells
Ken Takigawa, Noriaki Kawano, Yasuo Mori, et al.
Internal Medicine (Tokyo, Japan)
|
April 19, 2019
Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)
Noriaki Kawano, Noriaki Yoshida, Sayaka Kawano, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
June 28, 2023
The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL)
Noriaki Kawano, Hidemi Shimonodan, Yuri Nagahiro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 22, 2022
[Analysis of Prognostic Factors Considering Absolute Lymphocyte Count of Metastatic Breast Cancer Patients with Eribulin Mesylate Therapy-A Retrospective Study in a Single Institution]
Yuichi Ueda, Yuko Makino, Hideki Hidaka, et al.
International Journal of Hematology
|
July 11, 2018
Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia
Ayako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
International Journal of Hematology
|
March 1, 2018
Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan
Ayako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
Blood
|
November 15, 2014
Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator
Takuro Kameda, Kotaro Shide, Takumi Yamaji, et al.
Blood Cell Therapy
|
September 10, 2025
The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy
Takashi Shimakawa, Noriaki Kawano, Yuichiro Semba, et al.
Page
of 7